Healthcare: Digging Into Disappointment. What Investors Need To Know About Sarepta and Gilead Sciences' "Bad News"

Industry Focus

The Motley Fool

Interview, Money, Consumergoods, Business, Businessnews, Ceo, Technology, Investing, Stocks, Energy, Fool, Financial, Economy, Healthcare, News, Banking, Motley, Tech, Business News, Investments

4.6 • 854 Ratings

🗓️ 4 May 2016

⏱️ 19 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Discussing the details behind the FDA's negative vote on Sarepta's DMD drug and Gilead Sciences' sliding hepatitis C sales.

Transcript

Click on a timestamp to play from that location

0:00.0	This episode of Industry Focus is brought to you by Rocket Mortgage by Quicken Loans.
0:04.4	Rocket Mortgage brings the mortgage process into the 21st century with a fast, easy, and completely online process.
0:10.9	Check out Rocket Mortgage today at Quickin Loans.com slash Fool.
0:15.0	What happens when the FDA says no to a drug that's patients only hope?
0:20.0	We'll dig into the story of sereptop therapeutics and their rare disease drug
0:24.0	candidate on this health care edition of industry focus. After that we're going to
0:28.3	check back in on the hepatitis C landscape because we just can't help but talk
0:32.0	about Gilead Sciences.
0:33.5	I'm Christine Hargis and this is industry-focused health care.
0:37.3	It is May 4th, 2016 and so to make up for my utter lack of pop culture knowledge a couple episodes ago, let me welcome
0:44.8	Motley Fool Healthcare contributor Todd Campbell to the show with a resounding May the fourth be with you.
0:52.4	Is that better?
0:53.0	Hi Christine, how are you?
0:54.0	I'm doing great.
0:55.0	How are you doing today?
0:57.0	I'm doing excellent.
0:58.0	I think we've got two really interesting topics on our hands today.
1:01.0	Todd, are you ready to dig in?
1:02.0	I am. This is going to be a fascinating conversation. on April 25th on our hands today, Todd, are you ready to dig in?
1:02.8	I am.
1:03.8	This is going to be a fascinating conversation.
1:05.8	Indeed.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.